Types of Cancer We Treat

Colorectal Cancer

Our medical, surgical, and radiation oncologists, gastroenterologists, and radiologists provide comprehensive, coordinated treatment and seamless care for people with even the most complex colorectal cancers, all under one roof. We personalize your treatment plan based on the location of the tumor, how advanced it is, and its molecular and genetic features.

Our clinical trials provide new and promising treatment options for people with early and more advanced colorectal cancer. NYU Langone doctors also offer high-quality colon cancer screening at convenient locations throughout the New York City area.

Find a Doctor & Schedule
Diagnosis
Preventive Treatment
Surgery
Chemotherapy
Immunotherapy & Targeted Therapies
Radiation Therapy

Related News

Actor’s Death Highlights Racial Disparities in Colon Cancer
Read Story
Study Shows Promising Results for Cuff-Assisted Colonoscopy
Read Story
Artificial Intelligence Aids in Detecting Colon Polyps
Read Story
Dr. Mark Pochapin Explains New Colon Cancer Screening Rules
Read Story
Surgical Oncologists Collaborate to Save a Patient’s Life
Read Story
Expert Discusses Improving Cancer Screening in Black Men
Read Story
Doctors Use New Tool to Remove Gastrointestinal Lesions
Read Story
Common Symptoms of Colon Cancer
Read Story
Family Health Centers Offer Free Colorectal Cancer Screening
Read Story
Socioeconomic Status Predicts Survival in Anal Cancer
Read Story
Barbershop Outreach Helps to Prevent Colorectal Cancer
Read Story
Reaching Black Men in Barbershops Boosts Cancer Screening
Read Story

Clinical Trials and Research Studies

Phase 3

Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)

Learn More

Phase 2

A PHASE II RANDOMIZED CONTROLLED TRIAL OF NIVOLUMAB IN COMBINATION WITH BMS-986253 OR CABIRALIZUMAB IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) PATIENTS

Learn More

Phase 5

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

Learn More

Phase 5

A Phase 1/2 Study of Oral LOXO-292 in Patients With Advanced Solid Tumors Including RET Fusion-Positive Solid Tumors Medullary Thyroid Cancer and Other Tumors With RET Activation (LIBRETTO-001)

Learn More
View All Related Clinical Trials (6)